823 results
Page 9 of 42
6-K
EX-99.3
urtpglh
15 Dec 21
Current report (foreign)
2:50pm
6-K
EX-99.2
nw5vt
15 Dec 21
Current report (foreign)
2:50pm
6-K
EX-99.4
wfydk29z9p
15 Dec 21
Current report (foreign)
2:50pm
6-K
EX-99.2
z77y0f3c wuf
6 Dec 21
Current report (foreign)
2:45pm
6-K
EX-99.1
59lukquxljpbknn2qjmi
6 Dec 21
Current report (foreign)
2:45pm
6-K
EX-99.1
t51wdfik 2gx
22 Nov 21
Current report (foreign)
12:42pm
6-K
EX-99.1
n5jian sp
9 Nov 21
Sanofi completes acquisition of Kadmon
4:53pm
6-K
EX-99.1
d6cnrcbqfbt7
28 Oct 21
Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC
11:19am
6-K
EX-99.3
tzqthqpgye
26 Oct 21
Current report (foreign)
5:08pm
6-K
EX-99.1
2b0ssese6a
26 Oct 21
Current report (foreign)
5:08pm
6-K
EX-99.2
e2xghwpe80l7ew04is
26 Oct 21
Current report (foreign)
5:08pm
6-K
EX-99.1
chwy0ty9kyfberesiyv
15 Oct 21
New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021
2:05pm
6-K
EX-99.1
xsczvqvxqf2prv0jpjto
7 Oct 21
Current report (foreign)
1:08pm
6-K
EX-99.2
srd7qnq3btzhmsdga
30 Sep 21
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate
6:18am
6-K
EX-99.1
ymqsocm29td2ycxaijbj
30 Sep 21
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate
6:18am
6-K
EX-99.1
il7nn 4wuq
23 Sep 21
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic dermatitis to be presented at WCPD and EADV
1:54pm
6-K
EX-99.2
0tnrujrqs8r967l1 ua
23 Sep 21
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic dermatitis to be presented at WCPD and EADV
1:54pm
6-K
EX-99.1
mz2f3jwglob
14 Sep 21
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
9:38am
6-K
EX-99.1
629pip1ixe45v
10 Sep 21
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus
3:23pm
6-K
EX-99.2
8h1gu8k72
10 Sep 21
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus
3:23pm